Tampa, Florida – HCA Healthcare West Florida is now offering Bamlanivimab antibody infusions at three hospital sponsored clinics to non-hospitalized patients who have tested positive for COVID-19.  The U.S. Food & Drug Administration (FDA) granted Emergency Authorized Use of Bamlanivimab on November 21, 2020 for the treatment of COVID-19 patients experiencing mild to moderate symptoms who are considered high risk for progressing to severe COVID-19.  All three clinics below treat adults, and Brandon Regional Hospital also provides the therapy to qualifying children, ages 12 and older.  Please contact the clinics directly at the number provided for details and to schedule an appointment. 

About HCA West Florida 

HCA Healthcare West Florida provides a complete continuum of high-quality programs and services to meet the healthcare needs of residents and businesses throughout west Florida, caring for more than 1.2 million patients last year.  HCA Healthcare West Florida includes 15 hospitals, 27 ER locations, 13 ambulatory surgery centers, numerous physician practices, graduate medical education programs, a regional lab, and consolidated service center. Our hospitals include Blake Medical Center, Brandon Regional Hospital, Citrus Memorial Hospital, Doctors Hospital of Sarasota, Englewood Community Hospital, Fawcett Memorial Hospital, Largo Medical Center, Medical Center of Trinity, Memorial Hospital of Tampa, Northside Hospital, Oak Hill Hospital, Palms of Pasadena Hospital, Regional Medical Center Bayonet Point, South Bay Hospital and St. Petersburg General Hospital. HCA Healthcare West Florida is affiliated with HCA Healthcare, one of the nation’s leading providers of healthcare services. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine.